Modular Solution for Cosmetics Compliance
Check the Conformity of your Formulas
Secure your regulatory documents for each zone
Optimize on-site risk management
Manage your Safety Data Sheets efficiently
Automate your regulatory monitoring
Ensure the traceability of your substances
Maintain good HSE risk management
Home fragrance products present a unique set of challenges: they are designed to disperse scent, involve complex chemical compositions, and result in exposure through inhalation.
Recevez une fois par mois les dernières actus réglementaires et conseils d’experts.
Managing cosmetic compliance across multiple markets quickly becomes complex when relying on spreadsheets. This article examines the limits of manual data management and when a more structured approach becomes necessary.
CEPA developments in Canada influence how cosmetic ingredients are assessed and managed. Learn what cosmetic brands should anticipate and monitor.
Managing cosmetic regulatory data across the U.S., Canada, and Europe is no longer just a compliance issue. It is a data management challenge that directly impacts consistency, risk, and scalability for cosmetic brands.
Learn about the importance of the Product Information File (PIF) for cosmetic products, its components, and the challenges of compliance. Discover how COSMETIC Factory software can simplify PIF creation and ensure European regulatory compliance for your cosmetics.
In 2025, cosmetic, fragrance and home fragrance compliance has shifted to true global-by-design: brands must build products to meet EU, US, Canadian and emerging market (Taiwan, ASEAN, GCC) requirements from day one. EcoMundo’s blog explains this growing regulatory complexity—dermocosmetics, hair “skinification”, perfumes, digital tools & PLM—and shows how to secure ingredients, structure product files (PIF, DIP) and industrialize global compliance to stay competitive into 2026.
At the end of 2025, the Biocidal Products Committee failed to reach a consensus on the approval of ethanol as a biocidal active substance, pushing its opinion back to May 2026. This delay effectively extends the transitional period but leaves manufacturers and importers facing ongoing uncertainty when planning their product portfolios and authorisation strategies.
